Apheresis Market Trends, 2017-2025

Apheresis Market (Product - Devices and Disposables; Application - Renal Diseases, Neurology, Cancer, Hematology, Autoimmune Diseases, and Cardiovascular Diseases; Procedure - Plasmapheresis, Photopheresis, LDL Apheresis, Plateletpheresis, Leukapheresis, and Erythrocytapheresis; Technology - Centrifugation and Membrane Filtration; End User - Private Blood Collection Centers, Public Blood Collection Centers, and Hospitals) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Apheresis Market: Snapshot

According to the professional survey report by the Transparency Market Research, the global apheresis market was evaluated at US$ 1.85 billion at the beginning of the forecast period i.e. in 2016 and is likely to expand to reach the valuation of 4.33 billion at the end of the forecast period i.e. in 2025. The research report also predicts that the global apheresis market will record a noteworthy growth rate of 10.2 % during the forecast period i.e. 2017 to 2025. Some of the key drivers for the global apheresis market include rising applications of apheresis procedures in numerous neurological, cardiovascular, autoimmune, renal, and hematological applications.

global-apheresis-market

Advancements in Medical Technologies Boost Growth in Apheresis Market

Furthermore, the advancements in the medical technologies as well as the increasing popularity and population participation in blood donation drives and camps is anticipated to bolster the demand within the global apheresis market  in coming years. The types of products offered by the vendors and players operational within the global apheresis market are disposable as well as devices. Some of the leading applications for the solutions and products within the global apheresis market include neurology, cancer, cardiovascular diseases, diabetes, renal diseases, hematology, autoimmune diseases, and fibrosis, among others.

The segments in the global apheresis market classified by the type of procedure include photopheresis, plateletpheresis, erythrocytapheresis, extracorporeal immunoadsorption, plasmapheresis, LDL apheresis, leukapheresis, and lymphapheresis, among others. Among these, the photopheresis procedure segment is likely to dominate the global apheresis market in terms of growth, recording approximately 12.2 % growth within the forecast years. The segment of plasmapheresis led the global apheresis market in 2016, owing to the numerous applications of these procedures in plasma exchange in therapeutic processes.

Segments in the global apheresis market classified on the basis of technology used are membrane filtration technologies as well as centrifugation technologies. Some of the most prominent end users for the products and solutions offered by the players in the global apheresis market include blood collection centers, private, hospitals, and public.

Asia Pacific to Record Noteworthy Growth in the Apheresis Market in Near Future

Key regions covered in the business intelligence report on the global apheresis market are North America, Middle East and Africa, Europe, Latin America, and Asia Pacific. Among these, North America region led the global apheresis market in 2016, owing to the rising demand for plasma, intended for the production of medicines derived from plasma as well as the presence of well-trenched healthcare and medical infrastructure in the region. However, another region that is set to experience outstanding growth within the global apheresis market in coming years is Asia Pacific. The report predicts that the Asia Pacific region will record a substantial growth rate of 11.2 % in the global apheresis market over the forecast period.

Key trends influencing the demand dynamics within the Asia Pacific region in global apheresis market include increasing prevalence of various chronic diseases and health conditions, increase in the elderly regional population, and rising spending on medical and healthcare industries. Furthermore, the presence of substantial industry bases of global apheresis market in regional economies, such as China and India is also expected to foster the development of the Asia Pacific region in the global apheresis market in near future.

Some of the leading incumbent players and vendors working within the global apheresis market are Terumo Corporation, Fresenius Kabi AG, B. Braun Melsungen AG, NIKKISO Co., Ltd., Medica S. p. A., Asahi Kasei Medical Co. Ltd., Haemonetics Corporation, Cerus Corporation, Kawasumi Laboratories, Inc., and Therakos, Inc., among others.

The global apheresis market has been segmented as follows:

by Product Type

  • Devices
  • Disposables 

by Application

  • Renal diseases
  • Neurology
  • Hematology
  • Cancer
  • Autoimmune disease
  • Cardiovascular diseases
  • Others (e.g. Fibrosis, Diabetes, etc.) 

by Procedure

  • Plasmapheresis
  • Photopheresis
  • LDL-apheresis
  • Plateletpheresis
  • Leukapheresis
  • Erythrocytapheresis
  • Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.) 

by Technology

  • Centrifugation
  • Membrane Filtration 

by End-User

  • Hospitals
  • Blood Collection Centers
  • Public
  • Private 

by Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of apheresis market?

Apheresis Market is projected to reach a value of US$4.33 billion by the end of 2025

What is the anticipated CAGR of the apheresis market in the forecast period?

Apheresis Market is expected to grow at a CAGR of 10.20% during the forecast period

What are the key driving factors for the growth of the apheresis market?

Apheresis Market is driven by rising applications of apheresis procedures in numerous neurological, cardiovascular, autoimmune, renal, and hematological applications

Which is the rising prominent segment in the apheresis market?

The photopheresis procedure segment is likely to dominate the global apheresis market within the forecast years

Who are the key players in the global apheresis market?

Top key players in apheresis market are Medica S.p.A., Fresenius Kabi AG, Therakos, Inc., Kawasumi Laboratories Inc., Asahi Kasei Medical Co. Ltd., Terumo Corporation, NIKKISO CO., LTD., B. Braun Melsungen AG, Haemonetics Corporation, and Cerus Corporation

    1.Preface
        1.1.Market Definition and Scope
        1.2.Market Segmentation
        1.3.Key Research Objectives
        1.4.Research Highlights

    2.Assumptions and Research Methodology

    3.Executive Summary

    4.Market Definition
        4.1.Introduction
               4.1.1.Product/Service Definition
               4.1.2.Industry Evolution / Developments
        4.2.Market Overview
        4.3.Key Market Indicators
               4.3.1.Global Health Care Expenditure Scenario
        4.4.Market Dynamics
               4.4.1.Drivers
               4.4.2.Restraints
               4.4.3.Opportunities
        4.5.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, 2016 – 2024
               4.5.1.Market Revenue Projections (US$ Mn)
        4.6.Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Supply Demand Scenario
        4.7.Porter’s Five Force Analysis
        4.8.Event Impact Analysis
        4.9.Market Outlook

    5.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Product Type
        5.1.Introduction & Definition
        5.2.Key Findings / Developments
        5.3.Key Trends
        5.4. Market Size (US$ Mn) Forecast By Product Type
               5.4.1.Devices
               5.4.2.Disposables
        5.5. Market Attractiveness By Product Type

    6.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, By Application
        6.1. Introduction & Definition
        6.2. Key Findings / Developments
        6.3. Key Trends
        6.4. Market Size (US$ Mn) Forecast, By Application
               6.4.1.Renal diseases
               6.4.2.Neurology
               6.4.3.Hematology
               6.4.4.Cancer
               6.4.5.Autoimmune disease 
               6.4.6.Cardiovascular diseases 
               6.4.7.Others (e.g. Fibrosis, Diabetes, Dermatology etc.)
        6.5. Comparison Matrix
        6.6. Market Attractiveness By Application

    7.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Procedure
        7.1. Introduction & Definition
        7.2. Key Findings / Developments
        7.3. Key Trends
        7.4. Market Size (US$ Mn) Forecast By Procedure
               7.4.1.Plasmapheresis
               7.4.2.Photopheresis
               7.4.3.LDL-apheresis
               7.4.4.Plateletpheresis
               7.4.5.Leukapheresis
               7.4.6.Erythrocytapheresis
               7.4.7.Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)
        7.5. Comparison Matrix
        7.6. Market Attractiveness By Procedure 

    8.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Technology
        8.1. Introduction & Definition
        8.2. Key Findings / Developments
        8.3. Key Trends
        8.4. Market Size (US$ Mn) Forecast By Technology
               8.4.1.Centrifugation
               8.4.2.Membrane filtration
        8.5. Comparison Matrix
        8.6. Market Attractiveness By Technology

    9.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By End-User
        9.1. Introduction & Definition
        9.2. Key Findings / Developments
        9.3. Key Trends
        9.4. Market Size (US$ Mn) Forecast By End-User
               9.4.1. Hospitals 
               9.4.2. Blood Collection Centers
                        9.4.2.1.Public
                        9.4.2.2.private
        9.5. Comparison Matrix
        9.6. Market Attractiveness By End-User

    10.Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Region
        10.1. Key Findings
        10.2. Policies and Regulations
        10.3. Market Size (US$ Mn) Forecast By Region
               10.3.1. North America
               10.3.2. Europe
               10.3.3. Asia Pacific
               10.3.4. Latin America
               10.3.5. Middle East & Africa
        10.4. Market Attractiveness By Country/Region

    11.North America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
        11.1. Introduction & Definition
        11.2. Key Findings / Developments
        11.3. Key Trends
        11.4. Market Size (US$ Mn) Forecast, By Country
               11.4.1. U.S.
               11.4.2. Canada
        11.5. Market Size (US$ Mn) Forecast By Product Type
               11.5.1. Devices
               11.5.2.Disposables
        11.6. Market Size (US$ Mn) Forecast, By Application
               11.6.1. Renal diseases
               11.6.2. Neurology
               11.6.3. Hematology
               11.6.4. Cancer
               11.6.5. Autoimmune disease 
               11.6.6. Cardiovascular diseases 
               11.6.7. Others 
        11.7. Market Size (US$ Mn) Forecast By Procedure
               11.7.1. Plasmapheresis
               11.7.2. Photopheresis
               11.7.3. LDL-apheresis
               11.7.4. Plateletpheresis
               11.7.5. Leukapheresis
               11.7.6. Erythrocytapheresis
               11.7.7. Others 
        11.8. Market Size (US$ Mn) Forecast, By Technology
               11.8.1. Centrifugation
               11.8.2. Membrane filtration
        11.9. Market Size (US$ Mn) Forecast, By End User
               11.9.1.Hospitals 
               11.9.2.Blood Collection Centers
                        11.9.2.1.Public
                        11.9.2.2.private
        11.10. Market Attractiveness Analysis 
               11.10.1. By Country
               11.10.2. By Product Type
               11.10.3. By Application
               11.10.4. By Procedure
               11.10.5. By Technology
               11.10.6. By End User

    12.Europe Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
        12.1. Introduction & Definition
        12.2. Key Findings / Developments
        12.3. Key Trends
        12.4. Market Size (US$ Mn) Forecast, By Country
               12.4.1. Germany
               12.4.2. France
               12.4.3. U.K.
               12.4.4. Italy 
               12.4.5. Spain
               12.4.6. Rest of Europe
        12.5. Market Size (US$ Mn) Forecast By Product Type
               12.5.1. Devices
               12.5.2.Disposables
        12.6. Market Size (US$ Mn) Forecast, By Application
               12.6.1. Renal diseases
               12.6.2. Neurology
               12.6.3. Hematology
               12.6.4. Cancer
               12.6.5. Autoimmune disease 
               12.6.6. Cardiovascular diseases 
               12.6.7. Others 
        12.7. Market Size (US$ Mn) Forecast By Procedure
               12.7.1. Plasmapheresis
               12.7.2. Photopheresis
               12.7.3. LDL apheresis
               12.7.4. Plateletpheresis
               12.7.5. Leukapheresis
               12.7.6. Erythrocytapheresis
               12.7.7. Others 
        12.8. Market Size (US$ Mn) Forecast, By Technology
               12.8.1. Centrifugation
               12.8.2. Membrane filtration
        12.9. Market Size (US$ Mn) Forecast, By End User
               12.9.1.Hospitals 
               12.9.2.Blood Collection Centers
                        12.9.2.1.Public
                        12.9.2.2.private
        12.10. Market Attractiveness Analysis 
               12.10.1. By Country
               12.10.2. By Product Type
               12.10.3. By Application
               12.10.4. By Procedure
               12.10.5. By Technology
               12.10.6. By End User

    13.Asia Pacific Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
        13.1. Introduction & Definition
        13.2. Key Findings / Developments
        13.3. Key Trends
        13.4. Market Size (US$ Mn) Forecast, By Country
               13.4.1. Japan
               13.4.2. China
               13.4.3. India
               13.4.4. Australia
               13.4.5. Rest of Asia Pacific
        13.5. Market Size (US$ Mn) Forecast By Product Type
               13.5.1. Devices
               13.5.2.Disposables
        13.6. Market Size (US$ Mn) Forecast, By Application
               13.6.1. Renal diseases
               13.6.2. Neurology
               13.6.3. Hematology
               13.6.4. Cancer
               13.6.5. Autoimmune disease 
               13.6.6. Cardiovascular diseases 
               13.6.7. Others 
        13.7. Market Size (US$ Mn) Forecast By Procedure
               13.7.1. Plasmapheresis
               13.7.2. Photopheresis
               13.7.3. LDL-apheresis
               13.7.4. Plateletpheresis
               13.7.5. Leukapheresis
               13.7.6. Erythrocytapheresis
               13.7.7. Others 
        13.8. Market Size (US$ Mn) Forecast, By Technology
               13.8.1. Centrifugation
               13.8.2. Membrane filtration
        13.9. Market Size (US$ Mn) Forecast, By End User
               13.9.1.Hospitals 
               13.9.2.Blood Collection Centers
                        13.9.2.1.Public
                        13.9.2.2.private
        13.10. Market Attractiveness Analysis 
               13.10.1. By Country
               13.10.2. By Product Type
               13.10.3. By Application
               13.10.4. By Procedure
               13.10.5. By Technology
               13.10.6. By End User

    14.Latin America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
        14.1. Introduction & Definition
        14.2. Key Findings / Developments
        14.3. Key Trends
        14.4. Market Size (US$ Mn) Forecast, By Country
               14.4.1. Brazil
               14.4.2. Mexico
               14.4.3. Rest of Latin America 
        14.5. Market Size (US$ Mn) Forecast By Product Type
               14.5.1. Devices
               14.5.2.Disposables
        14.6. Market Size (US$ Mn) Forecast, By Application
               14.6.1. Renal diseases
               14.6.2. Neurology
               14.6.3. Hematology
               14.6.4. Cancer
               14.6.5. Autoimmune disease 
               14.6.6. Cardiovascular diseases 
               14.6.7. Others 
        14.7. Market Size (US$ Mn) Forecast By Procedure
               14.7.1. Plasmapheresis
               14.7.2. Photopheresis
               14.7.3. LDL-apheresis
               14.7.4. Plateletpheresis
               14.7.5. Leukapheresis
               14.7.6. Erythrocytapheresis
               14.7.7. Others 
        14.8. Market Size (US$ Mn) Forecast, By Technology
               14.8.1. Centrifugation
               14.8.2. Membrane filtration
        14.9. Market Size (US$ Mn) Forecast, By End User
               14.9.1.Hospitals 
               14.9.2.Blood Collection Centers
                        14.9.2.1.Public
                        14.9.2.2.private
        14.10. Market Attractiveness Analysis 
               14.10.1. By Country
               14.10.2. By Product Type
               14.10.3. By Application
               14.10.4. By Procedure
               14.10.5. By Technology
               14.10.6. By End User

    15.Middle East & Africa Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
        15.1. Introduction & Definition
        15.2. Key Findings / Developments
        15.3. Key Trends
        15.4. Market Size (US$ Mn) Forecast, By Country
               15.4.1. Saudi Arabia
               15.4.2. South Africa
               15.4.3. Rest of MEA
        15.5. Market Size (US$ Mn) Forecast By Product Type
               15.5.1. Devices
               15.5.2.Disposables
        15.6. Market Size (US$ Mn) Forecast, By Application
               15.6.1. Renal diseases
               15.6.2. Neurology
               15.6.3. Hematology
               15.6.4. Cancer
               15.6.5. Autoimmune disease 
               15.6.6. Cardiovascular diseases 
               15.6.7. Others
        15.7. Market Size (US$ Mn) Forecast By Procedure
               15.7.1. Plasmapheresis
               15.7.2. Photopheresis
               15.7.3. LDL-apheresis
               15.7.4. Plateletpheresis
               15.7.5. Leukapheresis
               15.7.6. Erythrocytapheresis
               15.7.7. Others
        15.8. Market Size (US$ Mn) Forecast, By Technology
               15.8.1. Centrifugation
               15.8.2. Membrane filtration
        15.9. Market Size (US$ Mn) Forecast, By End User
               15.9.1.Hospitals 
               15.9.2.Blood Collection Centers
                        15.9.2.1.Public
                        15.9.2.2.private
        15.10. Market Attractiveness Analysis 
               15.10.1. By Country
               15.10.2. By Product Type
               15.10.3. By Application
               15.10.4. By Procedure
               15.10.5. By Technology
               15.10.6. By End User

    16.Competition Landscape
        16.1. Market Player – Competition Matrix (By Tier and Size of companies)
        16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
               16.2.1.Asahi Kasei Medical Co., Ltd.
                        16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.1.2. Product Portfolio
                        16.2.1.3. SWOT Analysis
                        16.2.1.4. Financial Overview
                        16.2.1.5. Strategic Overview
               16.2.2. B. Braun Melsungen AG
                        16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.2.2. Product Portfolio
                        16.2.2.3. SWOT Analysis
                        16.2.2.4. Financial Overview
                        16.2.2.5. Strategic Overview
               16.2.3. Cerus Corporation 
                        16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.3.2. Product Portfolio
                        16.2.3.3. SWOT Analysis
                        16.2.3.4. Financial Overview
                        16.2.3.5. Strategic Overview
               16.2.4. Fresenius Medical Care
                        16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.4.2. Product Portfolio
                        16.2.4.3. SWOT Analysis
                        16.2.4.4. Financial Overview
                        16.2.4.5. Strategic Overview
               16.2.5. Haemonetics Corp.
                        16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.5.2. Product Portfolio
                        16.2.5.3. SWOT Analysis
                        16.2.5.4. Financial Overview
                        16.2.5.5. Strategic Overview
               16.2.6. Hemacare Corporation
                        16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.6.2. Product Portfolio
                        16.2.6.3. SWOT Analysis
                        16.2.6.4. Financial Overview
                        16.2.6.5. Strategic Overview
               16.2.7. Kawasumi Laboratories Inc.
                        16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.7.2. Product Portfolio
                        16.2.7.3. SWOT Analysis
                        16.2.7.4. Financial Overview
                        16.2.7.5. Strategic Overview
               16.2.8. Medica S.p.A.
                        16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.8.2. Product Portfolio
                        16.2.8.3. SWOT Analysis
                        16.2.8.4. Financial Overview
                        16.2.8.5. Strategic Overview
               16.2.9. NIKKISO CO., LTD.
                        16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.9.2. Product Portfolio
                        16.2.9.3. SWOT Analysis
                        16.2.9.4. Financial Overview
                        16.2.9.5. Strategic Overview
               16.2.10. Terumo Corporation
                        16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.10.2. Product Portfolio
                        16.2.10.3. SWOT Analysis
                        16.2.10.4. Financial Overview
                        16.2.10.5. Strategic Overview
               16.2.11. Therakos, Inc.
                        16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
                        16.2.11.2. Product Portfolio
                        16.2.11.3. SWOT Analysis
                        16.2.11.4. Financial Overview
                        16.2.11.5. Strategic Overview

    List of Tables:

    Table 01: Global Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 02: Global Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 03: Global Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 04: Global Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 05: Global Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 06: Global Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
    Table 07: Global Apheresis Market Size (US$ Mn) Forecast, by Region, 2015–2025
    Table 08: North America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 09: North America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 10: North America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 11: North America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 12: North America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 13: North America Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
    Table 14: North America Apheresis Market Value (US$ Mn) Forecast, by Country, 2015–2025
    Table 15: Europe Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 16: Europe Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 17: Europe Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 18: Europe Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 19: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 20: Europe Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
    Table 21: Europe Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
    Table 22: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Product, 2015–2025
    Table 23: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 24: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 25: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 26: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 27: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
    Table 28: Asia Pacific Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
    Table 29: Latin America Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 30: Latin America Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 31: Latin America Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 32: Latin America Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 33: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 34: Latin America Apheresis Market Value (US$ Mn) Forecast, by End-user (Blood Collection Centers), 2015–2025
    Table 35: Latin America Apheresis Market Value (US$ Mn) Forecast, by Country / Sub-region, 2015–2025
    Table 36: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
    Table 37: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Application, 2015–2025
    Table 38: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Procedure, 2015–2025
    Table 39: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Technology, 2015–2025
    Table 40: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user, 2015–2025
    Table 41: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by End-user (blood collection center), 2015–2025
    Table 42: Middle East & Africa Apheresis Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025

    List of Figures:

    Figure 01: Global Apheresis Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 02: Global Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 03: Global Apheresis Devices Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 04: Global Apheresis Disposables Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 05: Global Apheresis Market Attractiveness Analysis, by Product Type
    Figure 06: Global Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 07: Global Apheresis in Renal Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 08: Global Apheresis in Neurology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 09: Global Apheresis in Hematology Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 10: Global Apheresis in Cancer Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 11: Global Apheresis in Autoimmune Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 12: Global Apheresis in Cardiovascular Diseases Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 13: Global Apheresis in Other Applications Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 14: Global Apheresis Market Attractiveness Analysis, by Application
    Figure 15: Global Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 16: Global Plasmapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 17: Global Photopheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 18: Global LDL-Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 19: Global Plateletpheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 20: Global Leukapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 21: Global Erythrocytapheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 22: Global Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Procedures, 2015–2025
    Figure 23: Global Apheresis Market Attractiveness Analysis, by Procedure
    Figure 24: Global Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 25: Global Centrifugation Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 26: Global Membrane Filtration Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 27: Global Apheresis Market Attractiveness Analysis, by Technology
    Figure 28: Global Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 29: Global Apheresis Market Value Share Analysis, by End-user (blood collection centers), 2016 and 2025
    Figure 30: Global Hospitals Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 31: Global Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 32: Global Private Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 33: Global Public Blood Collection Centres Apheresis Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2025
    Figure 34: Global Apheresis Market Attractiveness Analysis, by End-user
    Figure 35: Global Apheresis Market Value Share Analysis, by Region, 2016 and 2025
    Figure 36: Global Apheresis Market Attractiveness Analysis, by Region
    Figure 37: North America Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 38: North America Market Attractiveness Analysis, by Country
    Figure 39: North America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 40: North America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 41: North America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 42: North America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 43: North America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 44: North America Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
    Figure 45: North America Apheresis Market Value Share Analysis, by Country, 2016 and 2025
    Figure 46: North America Apheresis Market Attractiveness Analysis, by Product Type
    Figure 47: North America Apheresis Market Attractiveness Analysis, by Application
    Figure 48: North America Apheresis Market Attractiveness Analysis, by Procedure 
    Figure 49: North America Apheresis Market Attractiveness Analysis, by Technology
    Figure 50: North America Apheresis Market Attractiveness Analysis, by End-user
    Figure 51: Europe Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection, 2017–2025
    Figure 52: Europe Apheresis Market Attractiveness Analysis, by Country / Sub-region
    Figure 53: Europe Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 54: Europe Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 55: Europe Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 56: Europe Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 57: Europe Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 58: Europe Apheresis Market Value Share Analysis, by End-User (Blood Collection Centers), 2016 and 2025
    Figure 59: Europe Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
    Figure 60: Europe Apheresis Market Attractiveness Analysis, by Product 
    Figure 61: Europe Apheresis Market Attractiveness Analysis, by Application
    Figure 62: Europe Apheresis Market Attractiveness Analysis, by Procedure 
    Figure 63: Europe Apheresis Market Attractiveness Analysis, by Technology
    Figure 64: Europe Apheresis Market Attractiveness Analysis, by End-user
    Figure 65: Asia Pacific Apheresis Market Size (US$ Mn) Forecast, 2017–2025
    Figure 66: Asia Pacific Apheresis Market Attractiveness Analysis, by Country
    Figure 67: Asia Pacific Apheresis Market Value Share Analysis, by Product, 2016 and 2025
    Figure 68: Asia Pacific Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 69: Asia Pacific Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 70: Asia Pacific Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 71: Asia Pacific Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 72: Asia Pacific Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
    Figure 73: Asia Pacific Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    Figure 74: Asia Pacific Apheresis Market Attractiveness Analysis, by Product 
    Figure 75: Asia Pacific Apheresis Market Attractiveness Analysis, by Application
    Figure 76: Asia Pacific Apheresis Market Attractiveness Analysis, by Procedure 
    Figure 77: Asia Pacific Apheresis Market Attractiveness Analysis, by Technology
    Figure 78: Asia Pacific Apheresis Market Attractiveness Analysis, by End-user
    Figure 79: Latin America Apheresis Market Size (US$ Mn) Forecast, 2017–2025
    Figure 80: Latin America Market Attractiveness Analysis, by Country / Sub-region
    Figure 81: Latin America Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 82: Latin America Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 83: Latin America Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 84: Latin America Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 85: Latin America Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 86: Latin America Apheresis Market Value Share Analysis, by End-user (Blood Collection Centers), 2016 and 2025
    Figure 87: Latin America Apheresis Market Value Share Analysis, by Country / Sub-region, 2016 and 2025
    Figure 88: Latin America Apheresis Market Attractiveness Analysis, by Product 
    Figure 89: Latin America Apheresis Market Attractiveness Analysis, by Application
    Figure 90: Latin America Apheresis Market Attractiveness Analysis, by Procedure 
    Figure 91: Latin America Apheresis Market Attractiveness Analysis, by Technology
    Figure 92: Latin America Apheresis Market Attractiveness Analysis, by End-user
    Figure 93: Middle East & Africa Apheresis Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
    Figure 94: Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
    Figure 95: Middle East & Africa Apheresis Market Value Share Analysis, by Product Type, 2016 and 2025
    Figure 96: Middle East & Africa Apheresis Market Value Share Analysis, by Application, 2016 and 2025
    Figure 97: Middle East & Africa Apheresis Market Value Share Analysis, by Procedure, 2016 and 2025
    Figure 98: Middle East & Africa Apheresis Market Value Share Analysis, by Technology, 2016 and 2025
    Figure 99: Middle East & Africa Apheresis Market Value Share Analysis, by End-user, 2016 and 2025
    Figure 100: Middle East & Africa Apheresis Market Value Share Analysis, by End-user (blood collection center), 2016 and 2025
    Figure 101: Middle East & Africa Apheresis Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
    Figure 102: Middle East & Africa Apheresis Market Attractiveness Analysis, by Product Type
    Figure 103: Middle East & Africa Apheresis Market Attractiveness Analysis, by Application
    Figure 104: Middle East & Africa Apheresis Market Attractiveness Analysis, by Procedure 
    Figure 105: Middle East & Africa Apheresis Market Attractiveness Analysis, by Technology
    Figure 106: Middle East & Africa Apheresis Market Attractiveness Analysis, by End-user

Copyright © Transparency Market Research, Inc. All Rights reserved